Cordelle Lazare, MD, MMed, MPH

Assistant Professor, Office of External Affairs
Cordelle Lazare
Contact Information

CLazare@rossu.edu

Biography

Dr. Lazare earned his Medical Degree from Nanchang University before pursuing post-graduate training in Obstetrics and Gynecology at Tongji Hospital - Tongji Medical College at Huazhong University of Science and Technology. His time in China also sparked his interest in research, which he further explored at the Key Laboratory of Cancer Invasion and Metastasis. Upon returning to the Caribbean, Dr. Lazare recognized the growing need for physicians with training in public health. This led him to pursue a Master of Public Health at St. George’s University, specializing in Health Policy and Administration.

In recent years, Dr. Lazare has dedicated his career to research, with a particular focus on cervical cancer and sexual and reproductive health. He has collaborated with key stakeholders to influence public health policy, including conducting research on medical perspectives on abortion and abortion laws in his home country of Dominica.

In 2025, Dr. Lazare joined Ross University School of Medicine as an Assistant Professor in the Office of External Affairs. His areas of expertise include gynecologic oncology, health policy, and sexual and reproductive health. 

Education
  • Medical/Doctoral Degree: Medical Degree, Nanchang University, Nanchang, Jiangxi, China, 2016
  • Other Degrees/Training: 
    • Master of Medicine (Obstetrics & Gynecology), Huazhong University of Science & Technology, Wuhan, Hubei, China, 2019
    • Master of Public Health (Health Policy & Administration), St. George’s University, Grenada, 2022 
Area of Expertise

Obstetrics & Gynecology, Public Health

Research Interests

 Gynecologic Oncology, sexual and reproductive health, maternal and child health

  1. Zhi, W., Wei, Y., Lazare, C., Meng, Y., Wu, P., Gao, P., Lin, S., Peng, T., Chu, T., Liu, B., Ding, W., Cao, C., & Wu, P. (2023). HPV-CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing. Journal of Medical Virology, 95(1), e28009. https://doi.org/10.1002/jmv.28009 
  2. Hem-Lee-Forsyth, S., Thomas, R., Pierre-Romain, L., Lewos-Charles, C., Lazare, C., Theodore, K., O’Reilly, S., Bryant, H., Patel, S. (2022). The economic and psychosocial effects of COVID-19 on alcohol use in Grenada during lockdown: a discussion on policy solutions to prevent harmful alcohol consumption. International Journal of Multidisciplinary Research and Analysis, 5(2). http://doi.org/10.47191/ijmra/v5-i2-01 
  3. Cao, C., Lin, S., Zhi, W., Lazare, C., Meng, Y., Wu, P., Gao, P., Wei, J., & Wu, P. (2020). LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype. Frontiers in Oncology, 10, 284. https://doi.org/10.3389/fonc.2020.00284 
  4. Cao, C., Xu, Q., Lin, S., Zhi, W., Lazare, C., Meng, Y., Wu, P., Gao, P., Li, K., Wei, J., Wu, P., & Li, G. (2020). Mapping long-range contacts between risk loci and target genes in human diseases with Capture Hi-C. Clinical and Translational Medicine, 10(5), e183. https://doi.org/10.1002/ctm2.183 
  5. Lazare, C., Zhi, W., Dai, J., Cao, C., Sookha, R. R., Wang, L., Meng, Y., Gao, P., Wu, P., Wei, J., Hu, J., & Wu, P. (2019). A pilot study comparing the genetic molecular biology of gestational and non-gestational choriocarcinoma. American Journal of Translational Research, 11(11), 7049–7062.  
  6. Lazare, C., Xiao, S., Meng, Y., Wang, C., Li, W., Wang, Y., Chen, G., Wei, J., Hu, J., Xue, M., & Wu, P. (2019). Evaluation of Cervical Intraepithelial Neoplasia Occurrence Following the Recorded Onset of Persistent High-Risk Human Papillomavirus Infection: A Retrospective Study on Infection Duration. Frontiers in Oncology, 9, 976. https://doi.org/10.3389/fonc.2019.00976 
  7. Wu, P., Xiong, H., Yang, M., Li, L., Wu, P., Lazare, C., Cao, C., Gao, P., Meng, Y., Zhi, W., Lin, S., Hu, J., Wei, J., Ma, D., Liu, J., Yin, P., & Xing, H. (2019). Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study. Gynecologic Oncology, 155(3), 436–443. https://doi.org/10.1016/j.ygyno.2019.10.003 
  8. Gao, P., Lazare, C., Cao, C., Meng, Y., Wu, P., Zhi, W., Lin, S., Wei, J., Huang, X., Xi, L., Chen, G., Hu, J., Ma, D., & Wu, P. (2019). Immune checkpoint inhibitors in the treatment of virus-associated cancers. Journal of Hematology & Oncology, 12(1), 58. https://doi.org/10.1186/s13045-019-0743-4  
  9. Fan, Y., Meng, Y., Yang, S., Wang, L., Zhi, W., Lazare, C., Cao, C., & Wu, P. (2018). Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing. Disease Markers, 2018, 4826547. https://doi.org/10.1155/2018/4826547 
  10. Sookha, R. R., Zhi, W., Shen, Y., Lazare, C., Wang, L., Meng, Y., Cao, C., Hu, J., & Wu, P. (2018). Clinical Value of Combining 18F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma. Journal of Cancer, 9(17), 3101–3108. https://doi.org/10.7150/jca.27206